Live MD Anderson Cancer Center News with Latest Updates

Live MD Anderson Cancer Center news and developments with the latest updates. Check out current MD Anderson Cancer Center news stories and find out what happened, what is going on with MD Anderson Cancer Center. Recent news updates about MD Anderson Cancer Center
MD Anderson and UT Austin Create Unique Data-Driven Collaboration to Eliminate Cancer Using Novel Mathematical
This Enigmatic Protein Sculpts DNA to Repair Harmful Damage
New Ranking Puts UT Austin Among Top Universities in World
Study shows sedentary behavior independently predicts cancer mortality
Combination biomarker predicts response to immune checkpoint therapy
MD Anderson and Philips collaborate to facilitate personalized oncology treatments and clinical trial matching
Drug with new approach on impeding DNA repair shows promise in first clinical trial
Inherited mutation increases risk of prostate cancer in men of African descent
MD Anderson and Rakuten Medical announce strategic alliance to advance Illuminox platform for cancer treatments
Adoptive T-cell therapy ADP-A2M4 targeting MAGE-A4 shows early activity
Novel targeted drug induced positive response for patients with von Hippel-Lindau disease-associated kidney cancer
MD Anderson and Innovent Biologics announce a strategic collaboration to develop anti-PD-1 therapy TYVYT
COVID-19 research funds back six new initiatives
Testing tuberculosis vaccine for COVID-19
Roots of language
Study finds no overall survival benefit, but improved quality of life with talazoparib
Enhanced recovery is an improved, cost-effective approach for breast reconstruction
Adult astrocytes key to learning, memory
International consortium investigates overactive immune cells as cause of COVID-19 deaths
Immunotherapy effective in metastatic prostate cancers with specific markers of immune activation
New therapeutic strategies proposed for some lung and kidney cancers
Pembrolizumab shows promise for some advanced, hard-to-treat rare cancers
MD Anderson implements restrictions due to 2019 novel coronavirus disease (COVID-19)
St. Jude finds cancer drug resistance genes and possibly how to limit their effects
Tissue-digging nanodrills do just enough damage
MD Anderson implements additional travel restrictions due to 2019 novel coronavirus disease (COVID-19)
Platinum-based Agents are Not Superior to Standard Chemotherapy for Patients with Breast Cancer
UVA Is Ready to Bust Some Brackets – In This Biomedical Research Challenge
MD Anderson returning to normal operations on Monday, March 2
Emergency response measures implemented due to City of Houston water supply disruption
MD Anderson implements emergency response measures due to city-wide water supply disruption
Combined therapy may improve clinical responses for endometrial, colorectal and gastric tumors
Osteosarcoma profiling reveals why immunotherapy remains ineffective
MD Anderson announces strategic collaboration with Denali Therapeutics to research and develop targeted therapies for neurodegenerative diseases
MD Anderson receives more than $20 million in CPRIT funding
Houston Dash join Dynamo, MD Anderson in Making Cancer History
Absent p53, oral cancers recruit and reprogram nerves to fuel tumor growth
CD19 CAR NK-cell therapy achieves 73% response rate in patients with leukemia and lymphoma
Study provides new understanding of mitochondria genome with potential for new avenues of treatment for multiple cancers
Study demonstrates liquid biopsy as effective predictor of stage III melanoma relapse and treatment
Lung cancer screening decision aid delivered through tobacco quitlines improves informed decision-making
Researchers identify immune-suppressing target in glioblastoma
Breast biopsies after neoadjuvant chemotherapy accurately predict presence of residual breast cancer
Residual cancer burden after neoadjuvant therapy can accurately predict breast cancer survival
CAR T-cell therapy effective for relapsed mantle cell lymphoma patients
Combination therapy more effective than chemotherapy alone for many newly diagnosed leukemia patients
MD Anderson-convened consortium provides first universal recommendations for pediatric patients with sinusoidal obstructive syndrome
Acupuncture reduces radiation-induced dry mouth for cancer patients